Precision Dosing of Vancomycin in Critically Ill Children (BENEFICIAL)
A Multicentric, Randomised Controlled Clinical Trial to Study the Impact of Bedside Model-informed Precision Dosing of Vancomycin in Critically Ill Children
Sponsor: Belgium Health Care Knowledge Centre
A PHASE4 clinical study on Vancomycin, this trial is completed. The trial is conducted by Belgium Health Care Knowledge Centre and has accumulated 10 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2025 — Feb 2026 [monthly]
Active Not Recruiting PHASE4
-
Mar 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE4
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
▶ Show 5 earlier versions
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
May 2023 — May 2024 [monthly]
Recruiting PHASE4
-
Jun 2022 — May 2023 [monthly]
Recruiting PHASE4
-
Apr 2021 — Jun 2022 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Dec 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Belgium Health Care Knowledge Centre
- University Ghent
- University Hospital, Ghent
For direct contact, visit the study record on ClinicalTrials.gov .